Wandercraft’s self-balancing exoskeleton wins FDA clearance
Wandercraft now plans to initiate a US market launch of its exoskeleton for supporting upright movement in paralysed patients in September 2026.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
